NEWS BRIEF · Research journal
Plasma proteomics identifies insulin resistance signatures predictive of cardiometabolic disease risk

From the report
Nature Metabolism, Published online: 16 November 2026; doi:10.1038/s42255-026-01662-1Integration of deep plasma proteomics with hyperinsulinaemic–euglycaemic clamp measurements enables the generation of a tissue-resolved molecular atlas of insulin resistance. A model derived from these signatures outperforms conventional surrogate markers in predicting cardiometabolic disease across large population cohorts.
